Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
cxsymposium2019-04-17T16:18:40+01:00Recorded presentation from CX Symposium 2019
Hence Verhagen, Rotterdam, Netherlands
Podium 1st: New developments in fusion imaging – artificial intelligence that deforms anatomy to maintain accuracy
cxsymposium2019-04-17T16:18:30+01:00Recorded presentation from CX Symposium 2019
Bijan Modarai, London, United Kingdom
Podium 1st: Potential EVAS cardiovascular mortality benefit through active sac management when compared to EVAR
cxsymposium2019-04-17T16:18:42+01:00Recorded presentation from CX Symposium 2019
Marc Schermerhorn, Boston, United States
CX Symposium provides “ideal opportunity” to share your research
cxsymposium2018-08-16T16:44:15+01:00In this interview, Meryl Davis, chair of the CX Abstract Board, talks about the benefits of presenting research at the CX Symposium and the importance of CX as a “global village”.
The CX Abstract Board is calling for senior and trainee doctors in the vascular and endovascular field to submit their […]
CX 2018: Podium 1st presentations
cxsymposium2018-06-22T10:13:35+01:00In addition to the plethora of late-breaking trials that were unveiled at this year’s Symposium, there was a vast array of Podium 1st presentations. These presentations showcased novel techniques and technologies, provided further insights into the safety and effectiveness of established devices, and highlighted potential solutions to current challenges in the management of vascular disease.
Peripheral […]
CX 2018 in numbers
cxsymposium2019-02-11T20:01:18+01:00
CX 2018 in numbers
This year’s CX welcomed more than 4,000 participants at Olympia London from a record-breaking 86 countries.
A leader of innovation, CX 2018 hosted a record-breaking 71 exhibitors and 15 new product launches—similar numbers are expected for CX 2019.
See the full stats and highlights in the video above.
Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
cxsymposium2018-04-26T13:54:50+01:00Ulf Teichgräber discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Ulf Teichgräber, Jena, Germany
EVAS is associated with a reduction in all-cause mortality
cxsymposium2018-04-25T19:14:01+01:00EVAS is associated with a reduction in all-cause mortality
Marc Schermerhorn, Boston, United States
Podium 1st: Lutonix AV IDE interim 24 month update
cxsymposium2018-04-26T13:27:11+01:00Podium 1st: Lutonix AV IDE interim 24 month update
Kate Steiner, Stevenage, United Kingdom
EVRA (Early Venous Reflux Ablation) Ulcer Trial presented for the first time at the Charing Cross Symposium
cxsymposium2018-04-24T15:50:47+01:00Alun Davies, EVRA chief investigator
Imperial College, London, United Kingdom
The CX Venous Workshop is the best in the world
cxsymposium2018-02-13T15:55:23+01:00Lowell Kabnick (New York, United States), who is a CX Faculty member, describes how the CX Venous Workshop has gone from being a small intimate session to one that, while still intimate, is “really large and all inclusive”. He adds that he believes that it is the best he has seen.
[…]
CX Venous Consensus Update: Take-home messages
cxsymposium2017-04-25T21:06:54+01:00The CX Venous Consensus Update—Plenary Programme took place on the first day of CX 2017 (Tuesday, 25 April). Stephen Black, member of the CX Programme Organising Board, summarises the take-home messages of this session.
CX is “one of the most prestigious” places for trainees to present abstracts
cxsymposium2017-10-19T15:46:55+01:00Pasha Normahani (Imperial Vascular Unit, Imperial Academic Health Science Centre, London, UK) has been an attendee at the Charing Cross (CX) Symposium for over seven years. In 2016, he presented for the first time at the CX Abstract sessions and was awarded with a Certificate of Merit for his research in peripheral arterial disease. In […]
Ian Loftus reviews highlights of the CX 2016 Abstract Presentations
cxsymposium2016-10-12T13:01:08+01:00Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted and how relevant it is for young and senior clinicians to present their research at the Charing Cross Symposium.
Why you should not miss the Peripheral Arterial sessions at CX 2016
cxsymposium2016-10-12T13:01:12+01:00“The Peripheral Arterial Programme at the Charing Cross Symposium in 2016 is really exciting; it combines the hot topics in the field with evidence, opinion and discussion,” says Andrew Holden (Auckland, New Zealand), member of the CX Programme Organising Board. He overviews key areas to be discussed on Tuesday 26 April including the management of […]
Why you should not miss the Venous Programme at CX 2016
cxsymposium2016-10-12T13:01:12+01:00In 2016, the Charing Cross Venous Programme will run on the four days of the Symposium (26–29 April) with the Main Programme for the first time on day 1, followed by the CX Venous Workshop on days 2 and 3, and the CX Venous Abstract Presentations on day 4. Ian Franklin (London, UK), member of […]
Stephen Black discusses the highlights of the CX 2016 Deep Venous programme
cxsymposium2016-10-12T13:01:12+01:00Stephen Black (London, UK), member of the CX Programme Organising Board, discusses the highlights of this year’s Deep Venous section of the CX Venous Challenges Day.
The CX Venous Challenges Day will take place at the Charing Cross Symposium on Tuesday 26 April – Lower Main Auditorium, Olympia Grand, London, UK
Click here to see the […]
Chairman Roger Greenhalgh highlights the most exciting aortic topics of CX 2016
cxsymposium2016-03-18T19:16:37+01:00“There has never been a more exciting expectation of what we have for this year in the aortic area at CX,” says Roger Greenhalgh, chairman of the CX Programme Organising Board. Results from the Individual Patient Data meta-analysis of the four randomised controlled trials on endovascular aneurysm repair against open repair (EVAR 1, DREAM, OVER […]
Interview with Michel Makaroun at CX 2015
cxsymposium2016-10-12T13:01:16+01:00Interview with Michel Makaroun at CX 2015
Interview with Matt Thompson at CX 2015: EndoVascular Aneurysm Sealing
cxsymposium2015-08-19T11:42:00+01:00
Interview with Ian Franklin at CX 2015: New venous technologies
cxsymposium2015-12-18T16:12:28+01:00Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX Venous Workshop.
Interview with Janet Powell at CX 2015: IMPROVE trial 12-month results
cxsymposium2015-08-07T15:50:00+01:00Janet Powell, Imperial College, London, UK, is interviewed about the 12-month results of the IMPROVE trial, presented for the first time at CX 2015. The study compares open repair and an endovascular strategy for ruptured abdominal aortic aneurysms.
GORE TAG Thoracic Branch Endoprosthesis – Interview with Michael Dake
cxsymposium2015-08-07T15:49:46+01:00Colin Bicknell, London, UK, interviews Michael Dake, Stanford, USA, discussing the use of, and early results for, the new GORE TAG Thoracic Branch Endoprosthesis device.
Reconstruction of the ascending aorta – Interview with Rodney White
cxsymposium2015-08-07T15:49:28+01:00Reconstruction of the ascending aorta – Interview with Rodney White
Interview for CX 2015